abstract |
The present invention relates to at least one novel anti-amyloid antibody, comprising isolated nucleic acids that encode at least one anti-amyloid antibody, an amyloid substance, vectors, host cells, transgenic animals or plants, and methods of manufacture and use thereof, comprising therapeutic compositions, methods and devices. |